Facetten
Zugriff
Einrichtung
Medientyp
- Text 20
Karte
Erscheinungsjahr
Autor/in
- Brümmendorf, Tim H
- Cortes, Jorge E 7
- Gambacorti-Passerini, Carlo 7
- Kantarjian, Hagop M 7
- Kim, Dong-Wook 6
- alle zeigen
Sprache
20 Einträge gefunden
-
Oncologic care capacity in German Comprehensive Cancer Centers during the first 2 years of the COVID-19 pandemic, Kapazität der onkologischen Versorgung in deutschen onkologischen Spitzenzentren während der ersten 2 Jahre der COVD-19-Pandemie
- Arndt, Volker
- Doege, Daniela
- Fröhling, Stefan
- Algül, Hana
- Bargou, Ralf C
- Bokemeyer, Carsten
- Bornhäuser, Martin
-
Telomere Shortening in Peripheral Leukocytes Is Associated With Poor Survival in Cancer Patients Treated With Immune Checkpoint Inhibitor Therapy
- Rolles, Benjamin
- Gorgulho, Joao
- Tometten, Mareike
- Roderburg, Christoph
- Vieri, Margherita
- Abels, Anne
- Vucur, Mihael
-
Serum levels of soluble B and T lymphocyte attenuator predict overall survival in patients undergoing immune checkpoint inhibitor therapy for solid malignancies
- Gorgulho, Joao
- Roderburg, Christoph
- Heymann, Felix
- Schulze-Hagen, Maximilian
- Beier, Fabian
- Vucur, Mihael
- Kather, Jakob N
-
Building a National Framework for Adolescent and Young Adult Hematology and Oncology and Transition from Pediatric to Adult Care: Report of the Inaugural Meeting of the "AjET" Working Group of the German Society for Pediatric Oncology and Hematology
- Escherich, Gabriele
- Bielack, Stefan
- Maier, Stephan
- Braungart, Ralf
- Brümmendorf, Tim H
- Freund, Mathias
- Grosse, Regine
-
-
-
Factors influencing long-term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib
- Brümmendorf, Tim H
- Cortes, Jorge E
- Khoury, Hanna J
- Kantarjian, Hagop M
- Kim, Dong-Wook
- Schafhausen, Philippe
- Conlan, Maureen G
-
-
Long-term efficacy and safety of bosutinib in patients with advanced leukemia following resistance/intolerance to imatinib and other tyrosine kinase inhibitors
- Gambacorti-Passerini, Carlo
- Kantarjian, Hagop M
- Kim, Dong-Wook
- Khoury, Hanna J
- Turkina, Anna G
- Brümmendorf, Tim H
- Matczak, Ewa
-
-
Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia:results from the 24-month follow-up of the BELA trial
- Brümmendorf, Tim H
- Cortes, Jorge E
- de Souza, Cármino Antonio
- Guilhot, Francois
- Duvillié, Ladan
- Pavlov, Dmitri
- Gogat, Karïn
-
-
Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up
- Gambacorti-Passerini, Carlo
- Brümmendorf, Tim H
- Kim, Dong-Wook
- Turkina, Anna G
- Masszi, Tamas
- Assouline, Sarit
- Durrant, Simon
-
Bosutinib: a novel second-generation tyrosine kinase inhibitor
2014 - Forschungsinformationssystem des UKE -
-
Bosutinib safety and management of toxicity in leukemia patients with resistance or intolerance to imatinib and other tyrosine kinase inhibitors
- Kantarjian, Hagop M
- Cortes, Jorge E
- Kim, Dong-Wook
- Khoury, H Jean
- Brümmendorf, Tim H
- Porkka, Kimmo
- Martinelli, Giovanni
-
A needle in a haystack: Identifying biomarkers to personalize systemic therapy in patients with hepatocellular carcinoma
2013 - Forschungsinformationssystem des UKE -
Combination of a proteomics approach and reengineering of meso scale network models for prediction of mode-of-action for tyrosine kinase inhibitors
- Balabanov, Stefan
- Wilhelm, Thomas
- Venz, Simone
- Amsberg, Gunhild
- Scharf, Christian
- Pospisil, Heike
- Balabanov, Melanie
-
-